GF
Gates Foundation Portfolio holdings
AUM
$43.5M
This Quarter Return
+27.55%
1 Year Return
+14.19%
3 Year Return
-58.08%
5 Year Return
–
10 Year Return
–
AUM
$651M
AUM Growth
+$651M
(+6.5%)
Cap. Flow
+$2M
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
ZY
Zymergen Inc. Common Stock
ZY
|
$2M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.26% |
| 2 | Materials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
BioNTech
BNTX
$24B
| $233M | 35.8% | 1,038,674 | – | – |
|
2
CureVac
CVAC
$1.21B
| $230M | 35.34% | 3,134,780 | – | – |
|
3
Vir Biotechnology
VIR
$686M
| $131M | 20.13% | 2,777,777 | – | – |
|
4
Immunocore
IMCR
$1.62B
| $23M | 3.53% | 576,923 | – | – |
|
5
Butterfly Network
BFLY
$405M
| $15M | 2.3% | 1,011,003 | – | – |
|
|
BCEL
6
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $12M | 1.84% | 1,396,644 | – | – |
|
|
AMRS
7
DELISTED
Amyris Inc.
AMRS
| $4.8M | 0.74% | 292,398 | – | – |
|
|
ZY
8
DELISTED
Zymergen Inc. Common Stock
ZY
| $2M | 0.31% | +59,970 | New | +$2M |
|